Specific killing of erbB-2-overexpressing tumor cells can be achieved using expression of an intracellular antibody directed against the erbB-2 oncoprotein. We have developed a strategy using a recombinant adenovirus encoding an anti-erbB-2 single chain antibody to achieve targeted tumor cell killing in vivo and can show significantly prolonged survival of animals carrying a human ovarian carcinoma tumor burden within their peritoneal cavities. This strategy of gene therapy for ovarian carcinoma offers the potential to achieve highly specific, targeted killing of human tumor cells and thus establishes the rationale to undertake human clinical trials on this basis.
J Deshane, G P Siegal, R D Alvarez, M H Wang, M Feng, G Cabrera, T Liu, M Kay, D T Curiel
Title and authors | Publication | Year |
---|---|---|
Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions
Y Tang, Y Cao |
Pharmaceutics | 2021 |
A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
N Silva-Pilipich, C Smerdou, L Vanrell |
Microorganisms | 2021 |
Neutralizing Anti-Hemagglutinin Monoclonal Antibodies Induced by Gene-Based Transfer Have Prophylactic and Therapeutic Effects on Influenza Virus Infection
T Yamazaki, J Chiba, S Akashi-Takamura |
Human vaccines | 2018 |
Antibody Engineering
T Böldicke |
2018 | |
Targeted Intracellular Delivery of Antibodies: The State of the Art
TA Slastnikova, AV Ulasov, AA Rosenkranz, AS Sobolev |
Frontiers in pharmacology | 2018 |
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma
H Matsuda, CG Campion, K Fujiwara, J Ikeda, S Cossette, T Verissimo, M Ogasawara, L Gaboury, K Saito, K Yamaguchi, S Takahashi, M Endo, N Fukuda, M Soma, P Hamet, J Tremblay |
Oncotarget | 2017 |
State of play and clinical prospects of antibody gene transfer
K Hollevoet, PJ Declerck |
Journal of Translational Medicine | 2017 |
The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo
JL Yang, XY Pan, WX Zhao, QC Hu, F Ding, Q Feng, GY Li, Y Luo |
International journal of oncology | 2016 |
A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth: Bispecific transmembrane antibody targeting EGFR
N Müller, C Hartmann, S Genßler, J Koch, A Kinner, M Grez, WS Wels |
International Journal of Cancer | 2013 |
The use of phage display to generate conformation-sensor recombinant antibodies
A Haque, NK Tonks |
Nature Protocols | 2012 |
State of the art in tumor antigen and biomarker discovery
K Even-Desrumeaux, D Baty, P Chames |
Cancers | 2011 |
Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability
GL Dobek, X Zhang, DA Balazs, WT Godbey |
The FASEB Journal | 2011 |
Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
K Ottolino-Perry, JA McCart |
Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer | 2010 |
Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer
G Wang, J Qiu, R Wang, A Krause, JL Boyer, NR Hackett, RG Crystal |
Cancer Gene Therapy | 2010 |
Intrabody and Parkinson's disease
C Zhou, S Przedborski |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2009 |
Therapeutic Antibodies
Y Chernajovsky, A Nissim |
2008 | |
Adenoviral vectors for gene therapy
JT Douglas |
Molecular Biotechnology | 2007 |
Novel antibodies as anticancer agents
I Zafir-Lavie, Y Michaeli, Y Reiter |
Oncogene | 2007 |
Gene therapy of gynaecological diseases
A Kanerva, M Raki, A Hemminki |
Expert Opinion on Biological Therapy | 2007 |
Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy
G Cabrera, SL Porvasnik, PE DiCorleto, M Siemionow, CK Goldman |
Molecular Cancer | 2006 |
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
H Griffin, R Elston, D Jackson, K Ansell, M Coleman, G Winter, J Doorbar |
Journal of Molecular Biology | 2006 |
Gene Transfer Approaches for Gynecological Diseases
M Raki, DT Rein, A Kanerva, A Hemminki |
Molecular Therapy | 2006 |
Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics
BC Heng, DM Kemeny, H Liu, T Cao |
Journal of Cellular and Molecular Medicine | 2005 |
Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: Potential advantages over antibodies expressed within the intracellular environment (Intrabody)
BC Heng, T Cao |
Medical Hypotheses | 2005 |
Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo
N Jendreyko, M Popkov, C Rader, CF 3rd |
Proceedings of the National Academy of Sciences | 2005 |
Cancer Gene Therapy
M Yamamoto, DT Curiel |
Technology in cancer research & treatment | 2005 |
Antibodies and gene therapy: teaching old ‘magic bullets’ new tricks
L Sanz, B Blanco, L Álvarez-Vallina |
Trends in Immunology | 2004 |
Intrabodies: production and promise
MR Stocks |
Drug Discovery Today | 2004 |
Ablating CAR and Integrin Binding in Adenovirus Vectors Reduces Nontarget Organ Transduction and Permits Sustained Bloodstream Persistence Following Intraperitoneal Administration
M Akiyama |
Molecular Therapy | 2004 |
Inhibition of endothelial cell surface expression of vascular endothelial growth factor receptor-2 using an intrabody strategy
Yurong Yang Wheeler, Timothy E. Kute, Mark C. Willingham, Si-Yi Chen, David C. Sane |
The FASEB Journal | 2003 |
Intracellular antibodies and challenges facing their use as therapeutic agents
MN Lobato, TH Rabbitts |
Trends in Molecular Medicine | 2003 |
Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Second Edition, Revised and Expanded
H Heslop, M Brenner, C Bollard |
Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Second Edition, Revised and Expanded | 2003 |
Intradiabodies, Bispecific, Tetravalent Antibodies for the Simultaneous Functional Knockout of Two Cell Surface Receptors
N Jendreyko, M Popkov, RR Beerli, J Chung, DB McGavern, C Rader, CF Barbas |
The Journal of biological chemistry | 2003 |
Intrabody and intrakine strategies for molecular therapy
YY Wheeler, SY Chen, DC Sane |
Molecular Therapy | 2003 |
Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies
O Artsaenko, K Tessmann, M Sack, D Häussinger, T Heintges |
Journal of General Virology | 2003 |
Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv–Fc intrabodies
RW Strube, SY Chen |
Journal of Immunological Methods | 2002 |
Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase
K Tessmann, A Erhardt, D Häussinger, T Heintges |
Journal of Virological Methods | 2002 |
Gene Therapy in Lung Disease
K Amin |
Gene Therapy in Lung Disease | 2002 |
Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth
K Palmer, N Sharan, P Emtage, J Gauldie, WJ Muller, Y Wan |
Gene Therapy | 2002 |
Genetically Engineered Intracellular Single-Chain Antibodies in Gene Therapy
G Bilbao, JL Contreras, DT Curiel |
Molecular Biotechnology | 2002 |
Intracellular Stability of Anti-caspase-3 Intrabodies Determines Efficacy in Retargeting the Antigen
A Rajpal, TG Turi |
The Journal of biological chemistry | 2001 |
Thoracic Oncology
DS Ettinger |
2001 | |
Using a Tropism-Modified Adenoviral Vector to Circumvent Inhibitory Factors in Ascites Fluid
JL Blackwell, H Li, J Gomez-Navarro, I Dmitriev, V Krasnykh, CA Richter, DR Shaw, RD Alvarez, DT Curiel, TV Strong |
Human Gene Therapy | 2000 |
Role of HER2 gene overexpression in breast carcinoma
S M�nard, E Tagliabue, M Campiglio, SM Pupa |
Journal of Cellular Physiology | 2000 |
Sensitivity of c‐erbB Positive Cells to a Ligand Toxin and Its Utility in Purging Breast Cancer Cells from Peripheral Blood Stem Cell (PBSC) Collections
M Keir, R Fiddes, JC Biggs, PP Kearney |
Stem Cells | 2000 |
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells
T Suzuki, B Anderegg, T Ohkawa, A Irie, O Engebraaten, M Halks-Miller, PS Holm, DT Curiel, M Kashani-Sabet, KJ Scanlon |
Gene Therapy | 2000 |
Gene Therapy for Lung Cancer
PJ Mosca, MA Morse, TA D'Amico, J Crawford, HK Lyerly |
Clinical Lung Cancer | 2000 |
Molecular and Genetic Aspects of Lung Cancer
WN Rom, JG Hay, TC Lee, Y Jiang, KM Tchou-Wong |
American journal of respiratory and critical care medicine | 2000 |
Advances in cancer gene therapy
G Bilbao, JL Contreras, DT Curiel |
Expert Opinion on Therapeutic Patents | 1999 |
Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
AA McCormick, MH Kumagai, K Hanley, TH Turpen, I Hakim, LK Grill, D Tusé, S Levy, R Levy |
Proceedings of the National Academy of Sciences | 1999 |
Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7
Q Zhu, C Zeng, A Huhalov, J Yao, TG Turi, D Danley, T Hynes, Y Cong, D DiMattia, S Kennedy, G Daumy, E Schaeffer, WA Marasco, JS Huston |
Journal of Immunological Methods | 1999 |
Characterization and Binding of Intracellular Antibody Fragments to the Hepatitis C Virus Core Protein1,2
T Heintges, J Putlitz, JR Wands |
Biochemical and Biophysical Research Communications | 1999 |
Gene therapy for carcinoma of the breast: Genetic ablation strategies
DT Curiel |
Breast Cancer Research | 1999 |
Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells
K Wiechen, S Karaaslan, A Turzynski, M Dietel |
British Journal of Cancer | 1999 |
A role for intracellular immunization in chemosensitization of tumor cells?
A Piché, C Rancourt |
Gene Therapy | 1999 |
c-erbB-2 as a target for immunotherapy
S Eccles |
Expert Opinion on Investigational Drugs | 1998 |
The Genetics of Ovarian Cancer
SE DePasquale, A Giordano, AE Donnenfeld |
Obstetrical & Gynecological Survey | 1998 |
Genetically Engineered Antibodies in Gene Transfer and Gene Therapy
M Pelegrin, M Marin, D Noël, M Piechaczyk |
Human Gene Therapy | 1998 |
Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice
MG Sacco, L Gribaldo, O Barbieri, G Turchi, I Zucchi, A Collotta, L Bagnasco, D Barone, C Montagna, A Villa, E Marafante, P Vezzoni |
Breast Cancer Research and Treatment | 1998 |
GENE THERAPY FOR LUNG CANCER
SM Dubinett, PW Miller, S Sharma, RK Batra |
Hematology/Oncology Clinics of North America | 1998 |
Radiosensitization mediated by a transfected Anti-erbB-2 single-chain antibody in vitro and in vivo
MA Stackhouse, DJ Buchsbaum, WE Grizzle, SJ Bright, CC Olsen, S Kancharla, MS Mayo, DT Curiel |
International journal of radiation oncology, biology, physics | 1998 |
Intracellular Expression of the Anti-erbB-2 sFv N29 Fails to Accomplish Efficient Target Modulation
JE Grim, GP Siegal, RD Alvarez, DT Curiel |
Biochemical and Biophysical Research Communications | 1998 |
Transductional Efficacy and Safety of an Intraperitoneally Delivered Adenovirus Encoding an Anti-erbB-2 Intracellular Single-Chain Antibody for Ovarian Cancer Gene Therapy
J Deshane, GP Siegal, M Wang, M Wright, RP Bucy, RD Alvarez, DT Curiel |
Gynecologic Oncology | 1997 |
A Novel Gene Therapy Strategy for Elimination of Prostate Carcinoma Cells from Human Bone Marrow
M Kim, M Wright, J Deshane, MA Accavitti, A Tilden, M Saleh, WP Vaughan, MH Carabasi, MD Rogers, RD Hockett, WE Grizzle, DT Curiel |
Human Gene Therapy | 1997 |
Conditionally replicative adenoviruses for cancer therapy
C Rancourt |
Advanced Drug Delivery Reviews | 1997 |
Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector
BE Rogers, DT Curiel, MS Mayo, KK Laffoon, SJ Bright, DJ Buchsbaum |
Cancer | 1997 |
Antibody engineering
MS Hayden, LK Gilliland, JA Ledbetter |
Current Opinion in Immunology | 1997 |
Gene therapy strategies for carcinoma of the breast
JM Ruppert, M Wright, M Rosenfeld, J Grushcow, G Bilbao, DT Curiel, TV Strong |
Breast Cancer Research and Treatment | 1997 |
Gene Therapy for Lung Cancer and Mesothelioma
SM Albelda |
Chest | 1997 |
Intracellular Antibodies
A Cattaneo, S Biocca |
1997 | |
The maturation of human gene therapy
T Friedmann |
Acta Paediatrica | 1996 |
Section Review Oncologic, Endocrine & Metabolic: Gene therapy for cancer therapeutics
G Bilbao, DT Curiel |
Expert Opinion on Therapeutic Patents | 1996 |
Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma
ME Rosenfeld, M Wang, GP Siegal, RD Alvarez, G Mikheeva, V Krasnykh, DT Curiel |
Journal of Molecular Medicine | 1996 |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |
New Comprehensive Biochemistry
S Yamamoto |
New Comprehensive Biochemistry | 1983 |